Patient Voice Agents
R

Rosemary

Rosemary is an AI agent for advance care planning, made by Affirm Health Inc. of Nashville, that calls high need Medicare patients from their own practice's number before a crisis. It times and retries calls and texts until a patient picks up, asks about a health care proxy, treatment preferences and what a good day looks like, and slows down when the conversation calls for it. Goals of care notes, POLST forms and hospice eligibility flags arrive as completed documents, and the practice's clinicians sign them with the patient through a built in digital signing flow before the record files to the EHR. Clinical questions, distress or a request for a family conference pass to Rosemary's human advance care planning facilitators with the conversation's context.

Risk bearing medical groups and accountable care organizations buy it per completed conversation: $35 across a full patient panel or $135 for the highest risk patients, with no seat license. In a six month pilot at an unnamed primary care ACO, covering three providers and 150 attributed high risk patients, the agent reached 119 of the 147 without an advance directive. Of those still needing one, 85 completed a discussion and 71 signed a directive, a do not resuscitate order or both, taking directives on file from 3 to 71. Mitch Evans founded Affirm Health in 2016, and its earlier clinician led planning software ran inside athenaClinicals at Ascension. Rosemary cites more than 500,000 conversations over ten years, a figure that includes the human led work it grew out of.

AI Health Index verifiedNovember 20, 2026
Compare Rosemary with other vendors
Founded
2016
Headquarters
Nashville, Tennessee
Categories
patient-facing-voice-agents, vbc-intelligence
Indexed Products
Rosemary advance care planning agent, Digital signing workflow
Buyer Segments
Risk bearing primary care groups, Accountable care organizations, Value based care organizations, Medicare population health teams
Assessment

Capability Axes

An AI Health Index grade measures what a buyer can verify from public sources on the date shown. It is not a rating of how good the product is. A vendor can build an excellent system and grade low on an axis because it publishes nothing an outsider can check. How grades read

AI Capability
AA on AI CentralityThe artificial intelligence is the product. Remove the model and there is nothing left to sell.
Vendor Published

The agent holds the conversation a trained facilitator used to hold. It places outbound calls and texts under the practice's identity, retries until the patient answers, asks about a proxy, treatment preferences and what a good day looks like, and turns the answers into goals of care notes, POLST forms and hospice eligibility flags ready for signature. Human facilitators take only the calls that need them, and the signing flow exists to finish what the agent prepared.

Affirm Health's earlier product supported conversations clinicians held at the point of care, while Rosemary moves the whole conversation to the agent, between visits, which is what the per conversation price pays for.

AA on Autonomy and Oversight ModelWhat the system may do and what it may not do are both published, with escalation thresholds, override paths and the conditions that route a case to a person.
Vendor Published

The agent's remit is the conversation and the paperwork, and it stops at three named triggers: a clinical question, patient distress or a request for a family conference, each handed to an advance care planning facilitator with the full context. Nothing becomes a care instruction until a clinician signs it with the patient in the digital signing flow, and in the pilot each finished conversation arrived as a note tied to the patient's next appointment.

The agent has no stated power to file an unsigned document or to answer a medical question itself. Patients can decline, and refusals run under 7%. The paperwork builds the review in, since a POLST or directive has no force without the signatures.

CC on Model and Technology TransparencyThe architecture is described in general terms with nothing identified. Proprietary is asserted rather than explained.
Vendor Published

The conversation follows protocols built during a decade of human led advance care planning, with the agent pacing itself and slowing down when a patient needs it, and the outputs are structured into goals of care notes, POLST forms and eligibility flags. That describes the agent's behavior in general terms.

Which speech recognition, voice and language models run the call, whether they are Affirm Health's own or licensed, what material adapted them to these conversations, and how a new version is tested before it reaches patients are not described. No model, version or update practice is named anywhere on the product's pages.

CC on Model Supply Chain DisclosureThe architecture is described and no model provider is named. Naming a hosting provider alone does not lift a record out of this band. Record the host in the note, because it matters for residency and breach scope, and grade on the model layer, which is the question this axis is named for.
Vendor Published

Three parties are visible: the practice that supplies the outreach list, Rosemary's human facilitators who take escalated calls, and the SMS service providers that deliver texts under a contract limiting them to delivery. The parties behind the voice call, transcription, dialogue and document generation are not named, and no subprocessor list exists.

Nothing says whether call audio or conversation content leaves Affirm Health for an outside model provider, or on what retention and training terms if it does. The SMS clause is the only supplier term on record, and it covers phone numbers rather than the content of a conversation about end of life care.

CC on Clinical and Operational EvidenceNamed customers, or vendor reported percentages with no method, denominator or reference standard. Scale of use is recorded here and is not treated as evidence of benefit.
Vendor Published

The one product study is a six month pilot at an unnamed primary care ACO with three providers and 150 attributed high risk patients, three of whom had an advance directive on file. The agent reached 119 of the 147 without one; 25 turned out to have a current directive, 85 of the remaining 94 completed a discussion and 71 signed a directive, a do not resuscitate order or both.

The $1.23 million in avoidable spending is modeled from an Aledade estimate of $14,500 per completed discussion published in AJMC rather than measured. The 71% connection rate and under 7% refusal rate are service wide figures with no period or denominator, and the 500,000 conversation total includes the human led years.

CC on AI Safety and PHI StewardshipGeneral assurances of privacy and security that do not answer the questions artificial intelligence raises: what is retained, what reaches a model, and what happens to it there.
Vendor Published

A conversation captures some of the most sensitive information a practice holds: treatment preferences, the name of a proxy, views on life sustaining treatment and signals of hospice eligibility. The only privacy terms cover the text program, limiting the mobile number to care related messages, keeping opt in data from third parties and binding SMS providers by contract to use the number only for delivery.

Nothing addresses call audio, transcripts, structured records or the drafts that become POLST forms: how long each is kept, whether recordings train the agent, whether identifiers are removed before processing, or how a conversation that goes wrong is handled.

Regulatory and Compliance
DD on HIPAA and BAA PostureNo statement of status and no privacy document that reaches the product. Both halves are absent at this grade: a service level privacy document on its own lifts a vendor to the band above even where no status is stated. A website privacy notice, including one that says it does not cover customer data, does not reach the product, so a vendor whose only document is that notice and who states no status grades here.
Vendor Published

Affirm Health operates Rosemary, and its SMS privacy policy covers only the patient's mobile number and text consent: numbers serve care related messages such as scheduling, reminders and care coordination, opt in data stays with the company, and SMS providers are contractually limited to delivery. The terms are likewise SMS terms for the messaging program alone.

The voice conversations, preferences, proxies, directives and signed orders the service handles for practices have no privacy document of their own, and no business associate status is stated anywhere, although the customers are medical groups sharing patient information with the service.

DD on Security Certifications and Trust CenterControls are asserted with nothing independent behind them, or nothing is published. Read the note before concluding anything: this is the grade most often corrected on a second pass, because assurance material frequently sits on a parent domain or inside an old announcement rather than on the product pages.
Vendor Published

No security certification, audit report, penetration test or trust center exists for Rosemary or Affirm Health, and the site makes no statement about encryption, access controls or how the digital signing environment is protected. The SMS policy's limits on sharing phone numbers are the only data handling commitments, and they concern messaging rather than the voice calls, recordings and signed orders that carry the service's most sensitive content. For a vendor holding advance directives and physician orders for life sustaining treatment, the security posture rests on whatever the sales process supplies, with nothing independent behind it.

DD on FDA and Regulatory StatusThe positioning is unclear or unsupported: clinical claims with no regulatory position stated, or language implying a status the databases do not carry. An open enforcement action that names the product also grades here, whatever the positioning: an FDA warning letter with no close out letter posted, or a consent decree in force. The note says which of the two applies, and the grade returns to the positioning bands when FDA closes the action.
Vendor Published

Two kinds of output carry clinical weight. POLST forms and goals of care notes record what a patient said and become orders only when a clinician signs them with the patient, which keeps them within documentation. The hospice eligibility flag is different: it arrives as a completed document like the others, yet eligibility for hospice turns on a clinical judgment about prognosis, and nothing says what criteria produce the flag, what basis the clinician sees behind it or whether the conversation record is available to check it. Rosemary states no regulatory position on any of its outputs, and the homepage calls its conversations clinically validated with no study behind the phrase.

CC on AI Governance and Bias DisclosureResponsible artificial intelligence is committed to in policy language with no evaluation behind it. Most of the index sits here.
Vendor Published

Every protocol the agent follows was validated in practice before it was automated, drawing on a decade of advance care planning conversations held by people, and the homepage calls the conversations clinically validated. The pilot reports completion at each step, from patients reached to directives signed, and the service cites a refusal rate under 7%.

No evaluation shows how the agent performs for patients with hearing loss, cognitive decline or limited English, or across cultural attitudes toward end of life care, the groups most likely to find a phone conversation on this subject hard. No outside review of the agent's conversations is named, so the commitment stays at the level of policy.

BB on AI Liability and RecourseA published falsifiable commitment, or a real correction route the affected person can exercise against the vendor. A published error rate with its method and denominator grades here. A statutory right that runs to the covered entity rather than to the vendor does not reach this band on its own: every other route here asks something of the vendor, and being located in a particular jurisdiction is not conduct.
Vendor Published

Payment is tied to delivery: Rosemary charges only when a conversation happens, and its stated promise is that it delivers the structured record or does not get paid. That commitment covers producing the record rather than the accuracy of what it says about a patient's wishes. The check on accuracy is the clinician, who signs each document with the patient through the digital signing flow, so a misheard preference can be corrected before it files to the chart. Patients can decline a call or stop texts by replying STOP. No warranty, correction route for a patient or family, or remedy for a signed document that misstates a preference is described.

Integration and Deployment
CC on EHR and Interoperability DepthIntegration is claimed through standards or a middleware layer with no system named and nothing to verify.
Vendor Published

Finished records file to the practice's EHR, where the homepage says they are findable at 2am in the emergency department. In the pilot, a note tied to the patient's upcoming appointment appeared in the record, and clinicians signed through a browser based flow with no separate inbox, system or list. Neither the pilot's record system nor any supported EHR is named, and the method, whether a standard interface, a document upload or a marketplace app, is not described. Affirm Health's earlier planning software worked inside athenaClinicals at Ascension, a connection that belongs to the earlier product rather than the voice agent.

DD on Deployment Model and Data ResidencyNothing published about where the system runs or where the data rests.
Vendor Published

Calls and texts go out under the practice's identity, finished documents file to the practice's EHR, and clinicians sign in a browser, but nothing says where the agent itself runs. The company's address is in Nashville. The region that processes voice, stores recordings, transcripts and structured records, and hosts the signing flow is not stated, and no option for a dedicated environment or customer controlled storage is offered. For records meant to be findable in an emergency department at 2am, the path from the call to the chart is described only from the practice's side.

Commercial
BB on Commercial TransparencyA price or a pricing basis is published without full tiers, so a buyer can size the cost before making contact.
Vendor Published

Two prices are posted: $35 per conversation across a full patient panel and $135 per conversation for the highest risk patients. Customers pay only when a conversation happens, with no seat licenses and no setup fees for outreach that does not connect. The suggested start is a pilot cohort, with expansion once completion rates are in, and a savings calculator models avoidable spending for panels from 100 to 20,000 patients.

Starting still means contacting the company, and volume commitments, contract length and any charge for filing to a particular EHR are not given. A practice can size both offers against its own panel before that first call.

BB on Setting and Specialty CoverageCoverage is named with validation behind part of it.
Vendor Published

The service targets high need Medicare patients with advanced illness, reached before a crisis, and sells to risk bearing medical groups, accountable care organizations and other value based care organizations responsible for those populations. The pilot ran in primary care, with outreach timed before appointments and physicians signing the resulting documents, and the expansion it set up covers 32 primary care providers and about 8,000 attributed patients.

Specialty settings such as oncology, nephrology or heart failure clinics, skilled nursing and home health are not named. Coverage in primary care has a pilot behind it, while the broader Medicare outreach offer rests on the decade of human led work.

Alternatives

Alternatives to Rosemary

Other products that do the same kind of work as Rosemary, and what each one does.

Arini builds AI agents for dental offices, dental groups and DSOs, led by an AI receptionist that answers inbound calls and texts around the clock, answers questions on insurance, hours and office policies, and books against the appointment types, providers and slots each practice sets…

Rivvi is an AI workspace for healthcare teams: a HIPAA covered alternative to general chat assistants where staff upload rosters, payroll runs, gap lists and documents, ask questions in plain language and get tables, charts and lists back.

Patient scheduling and access platform for provider organizations.

ActiumHealth is the healthcare patient communication product of Syllable, which acquired it in March 2024 and runs it as a division.

Blooming Health runs outreach, social care navigation and benefits renewal for health plans, health systems, government agencies, area agencies on aging and community organizations.

OhMD brings patient calls, text messages, web chat, and staff responses into a shared conversation history.

Commercial

Pricing

Vendor-published figures are labeled as such. Figures labeled “Estimated” are derived from third-party sources and have not been confirmed by the vendor.

Entry Price Pricing Basis BAA Tier Implementation Source
$35 per conversation
$35 baseline
$35 per completed conversation across a full patient panel and $135 per completed conversation for the highest risk patients. Customers pay only when a conversation happens, with no seat licenses. The SMS privacy policy covers the patient's mobile number and text consent. No business associate agreement or status is stated for the voice conversations and documents the service handles. No setup fee applies to outreach that does not connect. Any charge for filing documents to a particular EHR is not stated. Vendor Published

A practice can start with a pilot cohort and expand once completion rates are in. Volume minimums and contract length are not given.